Back to the Top 100
Cota Healthcare logo

Rank 100Data & Infrastructure

Cota Healthcare

Curates and analyzes deep oncology real-world data to help clinicians, research institutions, and life science companies improve cancer care.

Visit website
Signal Score
81.2
Total raised
$120M
Stage
Series D+
Founded
2011
Headquarters
New York, USA
Region
North America

Their signal

Cota structures fragmented electronic medical records into deep, regulatory-grade clinical oncological cohorts, helping pharmaceutical partners accelerate targeted cancer clinical trials and evidence generation.

Signal Score 81.2editorial estimate, see how it is built
Capital (25% weight)81

Total raised, quality of investors and recency of the last round.

Growth (25% weight)80

Revenue trajectory, customer count, hiring and market pull.

Clinical & regulatory (20% weight)86

Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.

Team (15% weight)83

Founder track record, clinical depth on the bench and technical leadership.

Online visibility (15% weight)75

Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.

Also in Data & Infrastructure

Figures are subjective research desk estimates compiled from public sources and refreshed daily, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.